Empagliflozin reduces risk of death in patients with heart failure and reduced ejection fraction – News-Medical.Net

Empagliflozin reduces the risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a reduced ejection fraction. That’s the finding of the EMPEROR-Reduced t… [read more]

Leave a Reply

Your email address will not be published. Required fields are marked *